 |
|
Afatinib-Induced Acute Fatal Pneumonitis in Metastatic Lung Adenocarcinoma
Sang Hoon Yoo, Jin Ah Ryu, Seo Ree Kim, Su Yun Oh, Gu Sung Jung, Dong Jae Lee, Bong Gyu Kwak, Yu Hyun Nam, Kyung Hyun Kim, Young Jun Yang
Korean J Fam Med. 2016;37(6):351-355. Published online 2016 Nov 18 DOI: https://doi.org/10.4082/kjfm.2016.37.6.351
|
|
Citations to this article as recorded by
 Life‐threatening pneumonitis after first‐line treatment with osimertinib for primary T790M mutated non‐small cell lung cancer
Maik Häntschel, Johannes Niebling, Almut Häring, Max‐Felix Häring, Thorben Groß, Marius Horger, Reimer Riessen, Michael Haap, Richard A Lewis, Michael Böckeler, Jürgen Hetzel
Thoracic Cancer.2020; 11(7): 2044. CrossRef Afatinib Associated Papulopustular Phototoxic Eruptions- A Novel Case Report
U. Zeenath Begum, M. Krishnakanth, Gayathri Rajesh, Mahalakshmi Veeraraghavan, Sudha R, S. Murugan
Biomedical and Pharmacology Journal.2019; 12(04): 1775. CrossRef The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis
Ke Ma, Yali Lu, Shanshan Jiang, Jiangong Tang, Xin Li, Yuyang Zhang
Frontiers in Pharmacology.2018;[Epub] CrossRef Pneumonitis After Precision Oncology Therapies: A Concise Review
Akash Jain, Vickie R. Shannon, Ajay Sheshadri
Journal of Immunotherapy and Precision Oncology.2018; 1(1): 26. CrossRef Treatment with a programmed cell death-1-specific antibody has little effect on afatinib- and naphthalene-induced acute pneumonitis in mice
Naoki Hamada, Toyoshi Yanagihara, Kunihiro Suzuki, Saiko Ogata-Suetsugu, Eiji Harada, Hironori Mikumo, Masako Arimura-Omori, Yoichi Nakanishi
Biochemical and Biophysical Research Communications.2017; 491(3): 656. CrossRef
|